Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach

BACKGROUND: Similarities in the hijacking mechanisms used by SARS-CoV-2 and several types of cancer, suggest the repurposing of cancer drugs to treat Covid-19. CK2 kinase antagonists have been proposed for cancer treatment. A recent study in cells infected with SARS-CoV-2 found a significant CK2 kin...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda, Jamilet, Bringas, Ricardo, Fernandez-de-Cossio, Jorge, Perera-Negrin, Yasser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686809/
https://www.ncbi.nlm.nih.gov/pubmed/34930105
http://dx.doi.org/10.1186/s10020-021-00424-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686809/
https://www.ncbi.nlm.nih.gov/pubmed/34930105
http://dx.doi.org/10.1186/s10020-021-00424-x

Ejemplares similares